drugset / Trial / NCT03991442
BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this clinical study is to evaluate the efficacy and safety by comparing the BR1010 treatment group to the fimasartan/amlodipine treatment group at Week 8 in patients with essential hypertension who do not adequately respond to Fimasartan/Amlodipine combination
Timeline
- Start
- 2019-06-17
- Primary completion
- 2021-03-02
- Completion
- 2021-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | — | — |
| Subject | Fimasartan | Small molecule | — | — |